Sorafenib-related generalized eruptive keratoacanthomas (Grzybowski syndrome): a case report

Sorafenib-related generalized eruptive keratoacanthomas (Grzybowski syndrome): a case report

Abstract Background Sorafenib is an oral multikinase inhibitor that targets Raf serine/threonine receptor tyrosine kinases and inhibits tumor cell growth and angiogenesis. Cutaneous toxicities of sorafenib are common, including cutaneous eruptions (such as truncal erythema and seborrheic-dermatitis-...

Full description

Bibliographic Details
Main Authors: M. Nazim Abbas, Wei Son Tan, Ganessan Kichenadasse
Format: Article
Language:English
Published: BMC 2021-09-01
Series:Journal of Medical Case Reports
Subjects:
Sorafenib
Grzybowski syndrome
Hepatocellular carcinoma
Online Access:https://doi.org/10.1186/s13256-021-03037-4

Similar Items

Similar Items